Company intelligence
Kitsa
Worlds Largest Clinical Research Network
About Kitsa
Kitsa helps teams launch clinical studies faster, powered by the world’s largest clinical research network. Our AI agents automate trial startup from protocol drafting to site selection and patient pre-screening, cutting months from study timelines. With AI-driven protocol development, global site intelligence across 100+ countries, and automated eligibility assessment using FHIR-based EHR connections, Kitsa helps sponsors and CROs move faster with confidence.
Verified activity
Signals from Kitsa
4 published signals
Research & Knowledge
KITSA is mapping Spain as a network of connected research ecosystems for clinical trials.
Reported by Kitsa
Research & Knowledge
Kitsa published a new analysis in the FDA and EMA joint Guiding Principles of Good AI Practice in Drug Development showing that 76% of Phase I–IV protocols now require at least one amendment, up from 57% in 2015.
Reported by Ajay Nyamati
Research & Knowledge
Kitsa published Trial Watch Edition 16 covering 15 high signal clinical trials across oncology, cardiometabolic disease, immunology, respiratory disease, and advanced modalities.
Reported by Kitsa
Customers & Market
Kitsa is expanding its coverage to France, including the France intelligence profile and the kitsa site network.
Reported by Kitsa